DATASET
IGBSCRFSGHKH_DATA_LABELS_2024-08-08_1145.csv (417.56 kB)
DATASET
IGBSCRFCHESHPH_DATA_LABELS_2024-08-08_1147.csv (635.05 kB)
DATASET
IGBSExtension_DATA_LABELS_2024-08-08_1142.csv (441.3 kB)
1/0
Feasibility study for the development of a sero-correlate of protection against invasive Group B Streptococcus disease (the iGBS study) - iGBS Feasibility
Primary objective
To establish a control group of GBS colonised women for the main seroepidemiology study
To test the feasibility of establishing national infant iGBS surveillance through our networks in preparation for the main seroepidemiology study
Secondary objectives
- To establish:
- the serotype-specific GBS anti-CPS IgG concentrations in cord blood in subjects colonised with GBS at delivery
- the rate of serotype-specific GBS anti-CPS IgG concentrations decline during the at risk period of the first three months of life
- an opt out approach to cord blood serum collection
Funding
National Institute for Health Research (NIHR) Health Technology Assessment programme (HTA 17/153/01).
History
Usage metrics
Categories
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC